Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q2- Text added to 2019 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
adult, advisor, alpha, compensatory, David, delisted, Employment, episodic, hard, Jane, Lawrence, negative, negotiated, opportunistically, permanent, plant, premium, suitability, Technical, top, warrant, Wasman
Removed:
abnormal, academic, Academy, accelerate, administering, advanced, affiliate, affiliated, Agency, Alkem, AmerisourceBergen, analyzed, ANDA, Apotex, Ascend, asserted, asserting, Aurobindo, blood, Bureau, candidate, center, challenged, chemistry, CHMP, Committee, conducted, consistent, convenient, Defense, define, demyelinating, distribute, earlier, elevation, EMA, expiration, FL, hepatoxicity, Human, imaging, import, Importantly, increased, infringe, infringement, injunctive, intact, integrated, judicial, launching, lesion, magnetization, manifested, Medicinal, meeting, Micro, myelin, myelination, Mylan, notification, obtaining, Overview, Paragraph, Pharma, pharmaceutical, population, ratio, relapse, removed, repair, requested, resolved, routed, Roxane, stopped, stopping, submission, Sun, Teva, therapy, timed, transfer, transplant, triptan, USA, VA, valid, validity, vigorously, walk, zolmitriptan
Valuein 2019 Q2 filing- Value in 2019 Q3 filing
Original filings
Filing view